![Petra Kaufmann](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Petra Kaufmann
Direttore Tecnico/Scientifico/R&S presso
OVID THERAPEUTICS INC.
Profilo
Petra Kaufmann is currently Chief Medical Officer at Ovid Therapeutics, Inc. since 2025.
Former positions include Chief Medical Officer at Affinia Therapeutics, Inc. from 2021 to 2024, SVP, Head-Clinical Development & Analytics at Novartis Gene Therapies, Inc. from 2020 to 2021, Director-Rare Diseases Research at National Institutes of Health from 2015 to 2018, and Chief Medical Officer at Vigil Neuroscience, Inc. Education includes a graduate degree from The Trustees of Columbia University in The City of New York and a doctorate from the University of Bonn.
Posizioni attive di Petra Kaufmann
| Società | Posizione | Inizio |
|---|---|---|
| OVID THERAPEUTICS INC. | Direttore Tecnico/Scientifico/R&S | 02/12/2025 |
Precedenti posizioni note di Petra Kaufmann
| Società | Posizione | Fine |
|---|---|---|
Affinia Therapeutics, Inc.
 Affinia Therapeutics, Inc. BiotechnologyHealth Technology Develops adeno-associated virus gene therapies | Direttore Tecnico/Scientifico/R&S | 01/03/2024 |
| AVEXIS INC | Corporate Officer/Principal | 01/02/2021 |
National Institutes of Health
 National Institutes of Health General GovernmentGovernment Engages in the improvement of health and saving lives | Corporate Officer/Principal | 01/02/2018 |
| VIGIL NEUROSCIENCE, INC. | Direttore Tecnico/Scientifico/R&S | - |
Formazione di Petra Kaufmann
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
51
Relazioni di 1° grado
7
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 7 |
|---|---|
Ovid Therapeutics, Inc.
 Ovid Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Provides medicines to children and adults with neurological disorders | Health Technology |
The Trustees of Columbia University in The City of New York
 The Trustees of Columbia University in The City of New York Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
National Institutes of Health
National Institutes of Health General GovernmentGovernment Engages in the improvement of health and saving lives | Government |
University of Bonn
 University of Bonn Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Novartis Gene Therapies, Inc.
 Novartis Gene Therapies, Inc. BiotechnologyHealth Technology Operates as a clinical-stage gene therapy company | Health Technology |
Affinia Therapeutics, Inc.
Affinia Therapeutics, Inc. BiotechnologyHealth Technology Develops adeno-associated virus gene therapies | Health Technology |
Vigil Neuroscience, Inc.
 Vigil Neuroscience, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biotechnology company that develops therapeutics for neurodegenerative diseases | Health Technology |
